MarketCap
Facebook
X
TelegramCryoLife, Inc. Revenue 2011-2025 | CRY
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue CryoLife, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 253 M | 276 M | 263 M | 190 M | 180 M | 146 M | 145 M | 141 M | 132 M | 120 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 276 M | 120 M | 185 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
848 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 96.13 | 0.04 % | $ 141 B | USA |
 |
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.6 | - | $ 125 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
1.59 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cutera
CUTR
|
49.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.57 B | $ 301.75 | 0.24 % | $ 8.51 B | USA |
 |
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | USA |
 |
Eargo
EAR
|
37.2 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
3.37 B | $ 48.12 | 0.21 % | $ 7.17 K | USA |
 |
Abbott Laboratories
ABT
|
42 B | $ 124.81 | 0.22 % | $ 217 B | USA |
 |
EDAP TMS S.A.
EDAP
|
44.1 M | $ 2.97 | 4.58 % | $ 111 M |  France |
 |
IRIDEX Corporation
IRIX
|
51.9 M | $ 1.14 | 3.64 % | $ 18.4 M | USA |
 |
IRadimed Corporation
IRMD
|
73.2 M | $ 97.06 | 0.48 % | $ 1.23 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
1.25 B | $ 63.08 | -0.27 % | $ 3.42 B |  Britain |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
Medigus Ltd.
MDGS
|
29.9 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Cognyte Software Ltd.
CGNT
|
443 M | $ 9.54 | - | $ 685 M | Israel |
 |
InMode Ltd.
INMD
|
358 M | $ 14.47 | 0.7 % | $ 1.15 B | Israel |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
4 B | $ 157.84 | 0.69 % | $ 11.8 B | USA |
 |
Myomo
MYO
|
1 B | $ 1.02 | 12.09 % | $ 7.19 M | USA |
 |
NanoVibronix
NAOV
|
2.56 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
459 M | $ 0.86 | 0.43 % | $ 88.4 M | USA |
 |
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
31.4 M | $ 14.49 | 0.84 % | $ 392 M | USA |
|
LENSAR
LNSR
|
53.5 M | $ 12.01 | -0.08 % | $ 138 M | USA |
 |
FONAR Corporation
FONR
|
97.6 M | $ 14.53 | 0.07 % | $ 95.2 M | USA |
 |
AxoGen
AXGN
|
187 M | $ 32.64 | -0.61 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
274 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
3.05 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
1.31 B | $ 40.17 | 1.34 % | $ 1.24 B | USA |
 |
NuVasive
NUVA
|
1.2 B | - | - | $ 2.07 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
205 M | $ 17.41 | 0.75 % | $ 402 M | USA |
 |
Globus Medical
GMED
|
2.52 B | $ 88.43 | -0.38 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.61 B | $ 12.66 | 0.56 % | $ 975 M | USA |